
OUTLOOK THERAPEUTICS INC
OTLKNASDAQπ #2785 by market capUS Equity
$133.77β² $10.70 (+8.00%)
Simulated price1hβ
24hβ² 8.0%
7dβ² 12824.6%
14dβ² 13079.3%
30dβ² 8475.0%
1yβ² 6362.3%
π¦Market Cap
$215M
Small Cap
πRevenue Growth (YoY)
β
πGross Margin
β
π΅FCF Margin
β
βοΈP/S Ratio
512.0x
Expensive
Otter Score
65
Fair
Trading Snapshot
- Day Range
- $132.84 β $136.42
- 52-Week Range
- $0.16 β $3.39
- Volume
- $2.81B
- Avg Volume
- $2.04B
- Shares Outstanding
- 187.0M
- Next Earnings
- Oct 17, 2026
Fundamentals Snapshot
- Annual Revenue
- $420,000
- Last Q Revenue
- $107,321
- P/E Ratio
- β
- P/S Ratio
- 512.0x
- EPS (TTM)
- $-1.26
- Dividend Yield
- β
Why Investors Own OTLK
- βHigh-growth profile β revenue up +29.8% YoY with expanding US Equity exposure.
- βHealthy economics β 57% gross margin and 15% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
β οΈ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$420,000β² +23.9% YoY
Gross Margin (TTM)
57.1%β² +0.6% YoY
Operating Income (TTM)
$156,240β² +23.9% YoY
Free Cash Flow (TTM)
$61,740β² +23.9% YoY
About OUTLOOK THERAPEUTICS INC
A company profile for OUTLOOK THERAPEUTICS INC isnβt available yet β check back soon.
π¦¦
Otter Score Breakdown
βπQualityβ
β
β
β
β
πGrowthβ
β
β
β
β
βοΈValuationβ
β
β
β
β
β‘Momentumβ
β
β
β
β
Overall Score
Fair
65/100
Analyst Price Target
βAverage Target
$172.08
β² +28.6% Upside
High Target$195.97
Low Target$147.33
Based on 36 analysts
Latest News & Updates
π
MarketWatchΒ·2h ago
OUTLOOK THERAPEUTICS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
π°οΈ
MarketWatchΒ·5h ago
Analysts lift OTLK price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
π
BloombergΒ·1d ago
OUTLOOK THERAPEUTICS INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.